Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - sertraline hydrochloride, quantity: 56 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; microcrystalline cellulose; sodium starch glycollate; hyprolose; magnesium stearate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; indigo carmine aluminium lake - children and adolescents,sertraline generichealth is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults,sertraline generichealth is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder.,sertraline generichealth is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse.,sertraline generichealth is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - sertraline hydrochloride, quantity: 111.92 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; sodium starch glycollate; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 400 - adults: setrona is indicated for the treatment of major depression. setrona is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - sertraline hydrochloride, quantity: 55.96 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; sodium starch glycollate; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 400 - adults: setrona is indicated for the treatment of major depression. setrona is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sertraline hydrochloride, quantity: 111.92 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; sodium starch glycollate type a; magnesium stearate; calcium hydrogen phosphate dihydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; peg-150 distearate; lauromacrogol 400 - children and adolescents sertraline hydrochloride is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults sertraline hydrochloride is indicated for: the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. sertraline hydrochloride is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. sertraline hydrochloride is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sertraline hydrochloride, quantity: 55.96 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; sodium starch glycollate type a; magnesium stearate; calcium hydrogen phosphate dihydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; peg-150 distearate; lauromacrogol 400 - children and adolescents sertraline hydrochloride is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults sertraline hydrochloride is indicated for: the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. sertraline hydrochloride is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. sertraline hydrochloride is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - modafinil, quantity: 100 mg - tablet, uncoated - excipient ingredients: purified talc; aluminium magnesium silicate; lactose monohydrate; povidone; croscarmellose sodium; maize starch; magnesium stearate - modafinil is indicated: ? to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy; ? to treat excessive sleepiness associated with moderate to severe chronic shift work sleep disorder where nonpharmacological interventions are unsuccessful or inappropriate; ? as an adjunct to continuous positive airways pressure (cpap) in obstructive sleep apnoea/hypopnoea syndrome in order to improve wakefulness.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sertraline hydrochloride, quantity: 111.9 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; hyprolose; sodium starch glycollate; calcium hydrogen phosphate dihydrate; macrogol 8000; hypromellose; macrogol 400; titanium dioxide; polysorbate 80 - children and adolescents: zoloft (sertraline hydrochloride) is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd. adults: zoloft (sertraline hydrochloride) is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. zoloft (sertraline hydrochloride) is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. zoloft (sertraline hydrochloride) is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sertraline hydrochloride, quantity: 55.95 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; calcium hydrogen phosphate dihydrate; magnesium stearate; sodium starch glycollate; macrogol 8000; hypromellose; macrogol 400; titanium dioxide; polysorbate 80 - children and adolescents: zoloft (sertraline hydrochloride) is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd. adults: zoloft (sertraline hydrochloride) is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. zoloft (sertraline hydrochloride) is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. zoloft (sertraline hydrochloride) is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sertraline hydrochloride, quantity: 55.95 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; calcium hydrogen phosphate; magnesium stearate; sodium starch glycollate; macrogol 8000; hypromellose; macrogol 400; titanium dioxide; polysorbate 80 - children and adolescents: zoloft (sertraline hydrochloride) is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd. adults: zoloft (sertraline hydrochloride) is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. zoloft (sertraline hydrochloride) is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. zoloft (sertraline hydrochloride) is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sertraline hydrochloride, quantity: 111.9 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; hyprolose; sodium starch glycollate; calcium hydrogen phosphate; macrogol 8000; hypromellose; macrogol 400; titanium dioxide; polysorbate 80 - children and adolescents: zoloft (sertraline hydrochloride) is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd. adults: zoloft (sertraline hydrochloride) is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. zoloft (sertraline hydrochloride) is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. zoloft (sertraline hydrochloride) is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.